|
HS Code |
754279 |
| Product Name | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine HCl |
| Cas Number | 137281-23-3 |
| Molecular Formula | C7H10ClNS |
| Molecular Weight | 175.68 g/mol |
| Appearance | White to off-white solid |
| Melting Point | 181-184°C |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Storage Conditions | Store at room temperature, keep container tightly closed |
| Synonyms | Tetrahydrothieno[3,2-c]pyridine hydrochloride |
| Chemical Class | Heterocyclic compound |
| Smiles | C1CC2=C(S1)NCC=C2.Cl |
| Inchikey | JJCPJWJVDSXSHG-UHFFFAOYSA-N |
As an accredited 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaged in a 25g amber glass bottle with tamper-evident cap, labeled with product name, CAS number, and safety instructions. |
| Container Loading (20′ FCL) | 20′ FCL container loads 10 MT of 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine HCl, packed in 25kg fiber drums. |
| Shipping | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine HCl is shipped in tightly sealed containers, protected from moisture and light. The chemical is packed according to safety regulations for hazardous substances, often with cushioning material, and accompanied by proper labeling and documentation. Transport is typically via reputable carriers under controlled temperature and handling conditions. |
| Storage | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine HCl should be stored in a cool, dry, and well-ventilated area away from direct sunlight and moisture. Keep the container tightly closed and clearly labeled. Store away from incompatible substances such as strong oxidizing agents and acids. Handle using appropriate personal protective equipment to prevent exposure. |
| Shelf Life | 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine HCl should be stored tightly sealed, protected from light and moisture; shelf life is typically 2-3 years. |
|
Purity 99%: 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl with 99% purity is used in pharmaceutical intermediate synthesis, where it enables high-yield and selective product formation. Melting Point 185-188°C: 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl with a melting point of 185-188°C is used in controlled solid formulation processes, where it ensures thermal stability during manufacturing. Molecular Weight 177.66 g/mol: 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl at 177.66 g/mol is used in medicinal chemistry research, where it facilitates accurate stoichiometric calculations for drug candidate development. Particle Size <50 µm: 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl with particle size below 50 µm is used in tablet formulation, where it improves homogeneity and dissolution rate. Stability Temperature up to 120°C: 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl with stability up to 120°C is used in hot-melt extrusion, where it maintains chemical integrity during processing. |
Competitive 4,5,6,7-Tetrahydrothieno[3,2,c] pyridine HCl prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In a world that demands ever-tighter tolerances and consistent product batches, every small step in the chemical manufacturing process shapes the backbone of downstream innovation. The molecule 4,5,6,7-Tetrahydrothieno[3,2-c]pyridine Hydrochloride, often identified in our workflow as Model TTP-HCl, represents one of those fine-tuned building blocks that make a dramatic difference when crafting everything from pharmaceutical intermediates to advanced agrochemical syntheses.
Decades spent on the factory floor have taught us that reliable supply, high purity, and process reproducibility mean far more than figures on a certificate of analysis. For chemists translating bench-scale ideas to industrial scale, any subtle shift in the feedstock can derail timelines and quality targets. We built our TTP-HCl process around meticulous synthesis controls and careful raw material selection, focusing on stability batch after batch.
Production starts with carefully sourced thiophene and pyridine ring components. Our technicians control each step under GMP-aligned guidelines. Closed-system handling starts right at the thieno-fused ring formation stage, where moisture and ambient air sensitivity of intermediates challenge even seasoned operators. In-process analytics, including HPLC purity checks, NMR and IR verification, guide each stage until the API-grade hydrochloride salt emerges.
Time and again, research customers point out that batch-to-batch variation can spell weeks of troubleshooting in the lab if not caught. We stand committed to in-house analytical confirmation across every batch. Typical lots of TTP-HCl reach purities of 99.0% or higher by HPLC, described as off-white to pale yellow crystalline solid due to trace, tightly controlled precursor influences. Melting points and spectral references are compared continuously with our in-house master samples.
Ask any process chemist what slows them down, and the answer circles back to two points: reliability of building-block molecules and supplier transparency. Years of feedback show that classic alternatives like 2-aminothiophenes or fully aromatic analogues often bring handling hurdles or extra steps to reach the target heterocycles found in finished pharmaceuticals.
What sets TTP-HCl apart is its balanced reactivity. The tetrahydropyridine scaffold, fused with a thienyl ring, builds in just enough conformational flexibility to facilitate downstream functionalization. Chemo-selectivity improves in processes that need site-specific alkylation, acylation, or oxidation steps. Our own kilo-lab scientists discovered early in scale-up trials that switching to TTP-HCl eliminated multiple purifications when chasing certain beta-blocker APIs compared to direct use of open-chain thienylpyridines.
Common synthetic detours involving earlier generation precursors typically forced longer reaction times, higher temperatures, or tedious chromatography to separate side products. Customers working in CNS-active drug discovery and cardiovascular research report that the hydrochloride salt offers better solubility in both water and mixed organic solvents, which smooths integration into automated synthesis lines. We keep records of dozens of successful optimizations shared with partnering R&D teams—from faster reductive aminations to sharper yield improvements by minimizing byproduct isomers.
Every manufacturer faces the balancing act between driving purity as close to theoretical max as feasible, and maintaining costs that don’t bottle-neck scaled projects. We focus on producing TTP-HCl in a format ideal for mid- to large-scale drug development and specialty synthesis. Package sizes range from 25g protected glass bottles to multi-kilogram HDPE drums with inert gas overlays to lock out moisture and potential cross-contamination.
While absolute absence of background impurities is normally a theoretical goal, our facility targets residual solvent and unreacted precursor limits well under ICH Q3A/B guidance for APIs and intermediates. Individual batch data sheets outline actual GC, NMR, and Karl Fischer results, kept on file and matched to each shipment. Our experience in customer audits has shown that accessible, real batch data helps research teams comply with their own internal regulatory filings and speeds up QA review.
We avoid over-polishing the product just for spec sheet bragging rights. Overzealous re-crystallization or solvent stripping can degrade yield or generate new isomer side products. The key lies in understanding the needs of the application: for most API steppings, the real challenge comes not from one isolated impurity at 0.02%, but from unpredictable seasonal or process variation in how those impurities behave during scale-up. Decades in production have taught us that a visibly “clean” solid analyzed via quick TLC can still surprise with ghost peaks in customer HPLC once it hits their specific formulation buffers or temperature regimes.
The dialogue between research chemists and factory engineers shapes our continuous improvement. Just five years ago, we ran our TTP-HCl crystallization under classic slow solvent-evaporation protocols. Yield hovered near 82%, but we noticed downstream partners had to compensate for sporadic color impurities—a result of micro-exposure to air during transfer. By refining our nitrogen-blanketed crystallization tanks and switching to inline filtration, the off-white product now registers less UV-visible color by five-fold, and process waste has dipped noticeably.
One important but often overlooked factor comes from material handling. Clumping on storage or minor HCl vapor emissions concern both lab managers and QA leads. Our solution relies on bulk vacuum-packing and double-layered HDPE bottle liners. These real-world tweaks minimize caking while locking down the hydrochloride salt, reducing handling time and guaranteeing consistent weigh-outs for both automated transfer and glove-box use.
We’ve learned from routine GMP audits that documentation and traceability drive long-term relationships. Our team logs each reactor run, batches all analytics in a networked database accessible for immediate lookup, and maintains reference spectra for at least three years post-lot. This goes beyond regulatory checkboxing; the cumulative experience of matching small details—like slight FTIR band shifts or low-level GC ghost peaks—to actual feedback from customer syntheses leads to tight process corrections and even design tweaks for clients at the scale-up phase.
Lab texts often treat heterocyclic intermediates as interchangeable, but practical projects reveal sharp differences. The fused tetrahydropyridine core of TTP-HCl participates in a select group of cyclization and coupling reactions without the harshness or unpredictability of simple thienopyridines. Our customers have shared that switching from unsubstituted pyridine hydrochloride to TTP-HCl opens up novel synthetic routes, especially for molecules with sensitive substituents that would otherwise decompose under classic Pechmann or Bischler-Napieralski conditions.
From a stability perspective, the hydrochloride counter-ion boosts storage shelf-life and limits volatility compared to free-base forms. Customers in advanced material chemistry appreciate this because lengthy synthesis pipelines raise the stakes for every intermediate. As product lines shift to volatile organic solvent-free protocols or automated continuous-flow reactors, TTP-HCl’s consistent reactivity profile enables chemists to introduce it early in route scouting without having to overhaul downstream process conditions later.
We encourage open exchange on application notes and technical support. Over dozens of customer projects, we’ve observed that TTP-HCl permits milder hydrogenation and reduction steps, outpacing older sulfonium-based thienopyridine intermediates both in speed and selectivity. For projects with green chemistry targets, this change means less solvent waste and reduced reliance on heavy metal catalysts. In agricultural R&D, the tetrahydro scaffold’s unique electronic properties have been leveraged to improve activity spectra in certain classes of herbicide and fungicide leads. Data from side-by-side pilot plant runs show the hydrochloride salt cuts post-reaction neutralization times, which has direct impact on throughput.
The reality facing chemical and pharmaceutical manufacturers today is a moving target of evolving regulatory pressure. It’s no longer enough to simply meet purity thresholds or deliver a clean batch; our customers need full transparency on origin, supply chain, and potential process contaminants. TTP-HCl produced in our facility stays fully traceable from initial feedstock and catalyst lot numbers all the way through to the validated packaging line. This includes detailed logs on all in-process controls, environmental monitoring, and any deviation reporting.
International customers ask us how we plan to keep pace as regulatory bodies introduce tighter nitrosamine and residual solvent guidelines. Our advantage comes from experience: We track leading publications and consortia guidance, shifting our own controls in parallel. For example, as concern around trace nitrosamine presence in nitrogen-containing heterocycles has grown, we invested in higher-sensitivity LC/MS methods and run routine screening for relevant byproducts in all regulatory-grade lots of TTP-HCl. No policy stands still in this industry, and our QA and compliance teams participate in roundtables and benchmarking exercises both to share findings and improve our own risk assessments.
Global shipping has changed in pace and predictability. Batches destined for regulated markets see additional verification through independent labs, triggered when new guidance hits or customer internal policy tightens. Our logistics team keeps a redundant network of certified partners for temperature- and humidity-controlled shipping, avoiding long port storage periods that could, in rare conditions, impact sensitive salts. The experience gathered from rush shipments of only a few grams to academic labs, up to full container loads for agro-industrial partners, helps us fine-tune both documentation trails and actual product stability data under real-world conditions.
Simply filling a drum or vial with TTP-HCl doesn't build the long-term partnerships we believe move the industry forward. Open technical dialogues drive process efficiency and real-world impact. We field dozens of queries each quarter regarding customized particle sizes, solvent-wetted formats, or specific certificate formats for in-process documentation. Certain application groups, such as those working in complex multistep alkaloid synthesis, prefer non-standard batch sizes or special inert packaging due to lab-scale optimization constraints. Our in-house team responds with quick samples drawn directly after QC, cutting weeks off typical order-to-sample cycles.
Feedback from high-throughput screening labs, contract manufacturing organizations, and regulatory filing specialists enables us to anticipate trends before they hit the order books. Recent shifts towards fully digital batch tracking, barcoding individual bottles, and sending spectral data through secure cloud portals have all been shaped by direct customer need—a process that’s led us to invest in both IT and process engineering to maintain that standard of responsiveness.
Industry events and technical working groups taught us that real value comes from manufacturers willing to adjust their product in light of on-the-ground feedback. For TTP-HCl, this translates to ongoing fine-tuning in our granulation, filtration, and drying steps based on live reports from scale-up partners. The process may introduce extra costs and operational hassle on our end, but the reward comes in long-term satisfaction scores and customer retention. Experienced chemists appreciate the extra clarity when a supplier shares the “why” behind every process tweak, especially when it reduces cycle time or smooths out supply dips during high-demand periods.
Many customers ask what future developments are on the horizon for a molecule that already sees wide application as a pharmaceutical intermediate and fine chemicals platform. The market signals a shift toward greener processes, renewable feedstock sourcing, and enhanced digital integration of manufacturing data. We see TTP-HCl fitting well into these trends, but improvement never stops. Continuous engineering trials look to shave solvent use, minimize process waste, and investigate the feasibility of alternate acid counter-ions for tunable solubility or environmental footprint reductions.
Synthetic access and process flexibility remain critical. Recent development projects explore new catalytic routes to the thieno[3,2-c]pyridine core, taking advantage of emerging transition-metal-catalyzed cyclizations and even biocatalytic options. Each modification aims to support customers reaching for more sustainable and cost-effective pipelines. Our own analytics team keeps benchmarking against new literature, ready to adapt next-generation monitoring technologies as they prove their worth in the fast-paced world of fine chemical supply.
Ultimately, the long-term story of TTP-HCl production is written not just in process diagrams or batch records but in shared experiences with real research and manufacturing teams. By staying open to regular feedback and building a repertoire of technical solutions meeting today’s—and tomorrow’s—challenges, we ensure that each shipment delivers more than just a high-purity powder: it brings the lessons, reliability, and shared commitment of years at the reactor and on the lab bench.
For us, manufacturing TTP-HCl isn’t about reaching a purity badge on a label or ticking off regulatory checklists. Instead, value comes from the hard-won lessons of process optimization, transparency in feedback, and willingness to improve. Failing a batch, catching unexpected spectroscopy anomalies, or digging up unanticipated storage requirements—these lessons shape not just the product, but our daily operation and client trust.
Years of direct manufacturing experience prove that a molecule’s journey from concept to finished good depends on engaged process development, transparent communication, and a fearless approach to continuous improvement. TTP-HCl’s role in advanced synthesis will only expand, and we stand ready to meet the next round of challenges alongside the chemists and engineers who depend on it.